Respiratory failure medical therapy

Respiratory failure Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Respiratory Failure from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
Electrocardiogram
CT
MRI
Echocardiography and ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical therapy
Oxygen therapy
Mechanical ventilation
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Respiratory failure medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Respiratory failure medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Respiratory failure medical therapy
CDC on Respiratory failure medical therapy
Respiratory failure medical therapy in the news
Blogs on Respiratory failure medical therapy
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Respiratory failure medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Overview

There is no treatment for respiratory failure; however, medication may be used to allow for easier intubation and to ease anxiety in the patient. Recently, studies have demonstrated a strong recommendation against the use of sedatives or analgesics. The use of these agents has been implicated in decreasing the success rates of ventilation mechanisms.

Medical Therapy

Medical therapy includes:

• Naloxone:
  • Naloxone is used as an antidote to opioid overdose - induced respiratory depression.
• Flumazenil:
  • Flumazenil is used as an antidote in benzodiazepine overdose - induced respiratory depression.
• Sedatives, activated charcoal and gastric emptying are all not recommended except in the rare case of hypercapnic respiratory failure with progressive respiratory acidosis with:
  • Anxiety
  • Rapid shallow breathing
  • Respiratory arrest
  • Moderate to severe expiratory airway resistance
  • Dynamic hyperinflation

Respiratory failure

• 1 Opiate overdose
  • 1.1 Naloxone
    • 1.1.1 Adult
      • Preferred regimen (1): Naloxone 0.05 mg IV initially, then titrated in increasing amounts every 5 minutes with a respriatory rate of 12 or greater

    Note (1): Apneic patients with suspected opiate overdose should receive higher first doses of naloxone between 0.2 - 1 mg

    Note (2): Cardiorespiratory with suspected opiate overdose should receive a minimum of 2 mg of naloxone

• 2 Benzodiazepine overdose
  • 2.1 Flumazenil
    • 2.1.1 Adult
      • Preferred regimen (1): Flumazenil 0.2 mg IV over 30 seconds

    Note (1): Repeated doses of 0.2 mg up to 1 mg if desired effect not achieved

    Note (2): Maximum dose of 3mg is given within any hour